SYNB1020 ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
251	尿素サイクル異常症	1

251. 尿素サイクル異常症

---

臨床試験数 : 48 /  薬物数 : 52 - (DrugBank : 13) / 標的遺伝子数 : 4 - 標的パスウェイ数 : 29

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03179878 (ClinicalTrials.gov)	June 16, 2017	6/6/2017	Safety and Tolerability of SYNB1020-CP-001	A Phase 1, First-in-human, Oral Single and Multiple Dose-Escalation, Randomized, Double-blinded, Placebo-controlled Study of SYNB1020 in Healthy Adult Volunteers to Evaluate Safety, Tolerability, Dosing, and Pharmacodynamics	Healthy Volunteer;Urea Cycle Disorder	Drug: Placebo;Drug: SYNB1020	Synlogic	NULL	Completed	18 Years	64 Years	All	52	Phase 1	United States